vimarsana.com
Home
Live Updates
Safety and immunogenicity of aerosolised Ad5-nCoV, intramusc
Safety and immunogenicity of aerosolised Ad5-nCoV, intramusc
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial
A heterologous fourth dose (second booster) with either aerosolised Ad5-nCoV or intramuscular
Ad5-nCoV was safe and highly immunogenic in healthy adults who had been immunised
with three doses of CoronaVac.
Related Keywords
Long Li ,
Jiangxi ,
China ,
United States ,
Donghai ,
Guangdong ,
Stockholm ,
Sweden ,
Lianshui ,
Shaanxi ,
Nanjing ,
Jiangsu ,
Peng Wan ,
Hubei ,
Xue Wang ,
Tao Zhu ,
J Clin Microbiol ,
Hai Tao Huang ,
Cansino Biologics ,
Technology Plan ,
National Natural Science Foundation Of China ,
Elsevier Ltd ,
Vazyme Medical Technology ,
Pearson ,
Graphpad Prism ,
Jiangsu Province ,
Nat Med ,
N Specific Igg ,
Clin Microbiol ,
Specifict Cell ,
Power Analysis ,
Sample Size ,
National Natural Science Foundation ,
Jiangsu Provincial Science Fund ,
Distinguished Young Scholars ,
Jiangsu Provincial Key Project ,
Continuous Vapouring System ,